Comparative Analysis of Adverse Effects: Protein Kinase Inhibitors Versus Traditional Anticancer Therapies

Comparative Analysis of Adverse Effects: Protein Kinase Inhibitors Versus Traditional Anticancer Therapies

The adverse effects of protein kinase inhibitors (PKIs) and other anticancer therapies were compared using FDA Adverse Events Reporting System (FAERS) data. The dataset included 159 FDA-approved anticancer drugs (71 PKIs, 88 nonPKIs) and analyzed 8216 unique adverse event (AE) terms. PKIs showed few...

Full description

Saved in:
Bibliographic Details
Main Authors: Ioana Lavinia Radulian, Georgiana Nitulescu, Anca Zanfirescu, George Mihai Nitulescu
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Scientia Pharmaceutica
Subjects:
pharmacovigilance
drug-related side effects
target-specific safety profile
oncology pharmacotherapy
adverse effects
adverse events
Online Access:https://www.mdpi.com/2218-0532/93/2/20
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items